P377 Impact of moderate-to-severe endoscopic disease criteria on endoscopic response, endoscopic remission, and deep remission in patients receiving ustekinumab or adalimumab in the SEAVUE study

Saved in:
Bibliographic Details
Published in:Journal of Crohn's and colitis 2022-01, Vol.16 (Supplement_1), p.i379-i380
Main Authors: Allez, M, Lewis, J D, Hanauer, S B, Danese, S, Irving, P M, Gasink, C, Hoops, T, Izanec, J L, Ma, T, Loftus, E V, Scherl, E J, Panaccione, R, Sandborn, W J, Sands, B E
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1873-9946
1876-4479
DOI:10.1093/ecco-jcc/jjab232.504